IMAT - Oncomedica

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Type 2 diabetes

Closed trials

• Completed

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· Phase 3· Novo Nordisk A/S· Source